under-detection of influenza-associated outcomes by surveillance. 4 CDC therefore estimates excess hospitalizations and deaths due to a range of diagnoses during periods of influenza circulation. 5 However, national burden estimates may not specifically inform allocation of resources at the state or local public health level for prevention and response, and national rates may not reflect local populations or influenza circulation. The application of similar estimation methods to state-level data has the potential to provide local burden estimates that complement existing influenza surveillance. We, therefore, adapted CDC's methods and analogous methods from similar studies to estimate influenza excess hospitalizations and deaths in Colorado. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] We demonstrate that periodic disease burden estimates are feasible and provide additional information about serious influenza outcomes not routinely available in a state.
| ME THODS

| Study design and study population
We estimated the burden of severe influenza in Colorado, a state with a population of 5.5 million people, from July 1, 2007, through June 30, 2016. 17 Outcomes included influenza excess pneumonia and influenza (P&I) and respiratory and circulatory (R&C) hospitalizations and deaths. Estimates of these outcomes were obtained using regression models of weekly hospital discharges and deaths on circulating influenza over 469 weeks. The regression models identified numbers and rates of P&I and R&C hospitalizations and deaths during the influenza season that were in excess of a seasonal baseline. Population denominators were taken from the American Community Survey. 17 
| Hospitalization and death data
To estimate influenza excess P&I and R&C hospitalizations and deaths, we first identified P&I and R&C hospitalizations and deaths recorded in statewide non-federal acute care hospital discharge data and death certificate data provided by the Colorado Department of Public Health and Environment. P&I hospitalizations and deaths included records with a respective primary discharge diagnosis or underlying cause of death coded by ICD-9 codes 480-488 or ICD-10 codes J09-J18. R&C hospitalizations and deaths included records with a respective primary discharge diagnosis or underlying cause of death coded by ICD-9 codes 390-519 or ICD-10 codes I00-I99 or J00-J99. These diagnoses groups were aggregated to weekly counts.
| Viral surveillance data
The primary predictor of influenza excess P&I and R&C hospitalizations and deaths was the overall weekly percent of influenza tests in Colorado that were positive for influenza by type and subtype. These data were obtained from a representative sample of sentinel laboratories that provided influenza virus surveillance data to the Colorado Department of Public Health and Environment during the winter respiratory season from October through May of the next year. Tests were ordered at the discretion of the ordering physician and included a combination of molecular assays and antigen detection tests. Statelevel data included the weekly number of tests performed and the number of tests positive for influenza A and B, without further subtyping of influenza A. Influenza A subtypes were assigned in proportion to the weekly ratio of H1N1 to H3N2 in CDC Region 8 (Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming). 3, 18 We then calculated weekly percentages of influenza tests positive for A(H1N1), A(H3N2), and B.
We used single imputation to assign values for percent of influenza tests positive for weeks outside the period of seasonal surveillance. In general, this involved setting values for weeks in June through August to zero. However, the first wave of the influenza A (H1N1) pandemic occurred during the summer of 2009, 19 
| Time-series regression models
Statistical analyses included a basic negative binomial model that was fit separately for P&I and R&C hospitalizations and deaths by F I G U R E 1 Negative binomial model used to estimate excess hospitalizations and deaths associated with influenza A(H1N1), A(H3N2), and B. E(Y i ) is the expected number of hospitalizations or deaths at week i. α is the population offset taken from the American Community Survey 1-year estimates assuming linear weekly growth between years. 17 It is the number of the week in the time series. β 0 is the intercept. β 1 through β 3 are coefficients associated with baseline linear, quadratic, and cubic time trends. β 4 and β 5 are coefficients associated with baseline seasonal changes. β 6 -β 10 are coefficients associated with percentages of specimens testing positive for each influenza virus type and subtype during a given week. Separate coefficients captured the effect of influenza A(H1N1) during pre-pandemic, pandemic, and post-pandemic periods. See the text for model fitting methods E(Y i ) = α*exp(β 0 + β 1 *t i + β 2 *t i 2 + β 3 *t i 3 + β 4 *sin(2t i π/52) + β 5 *cos(2t i π/52) + Model fitting incorporated the Akaike information criterion (AIC) and likelihood ratio tests. 20 First, the basic model was constructed with lag periods of 0, 1, 2, or 3 weeks between virus surveillance findings and hospitalization or death, and AIC was used to select the best-fitting lagged model (Table S1 ). The lag structure (0-3 weeks) was held the same for each influenza type and subtype in an individual model. Next, the significance of β 1 -β 3 was evaluated using the combination of AIC and the likelihood ratio test, and corresponding variables were eliminated if they did not improve model fit. 20 The re- Excess P&I and R&C hospitalizations and deaths were defined as the difference in model-predicted outcomes in the presence and absence of circulating influenza. These were obtained by taking the weekly predictions from the appropriate model and sequentially subtracting the weekly predictions from the same model applied to a dataset where circulation of the individual influenza type and subtype of interest was set to zero. The weekly differences between model predictions were summed over time. We estimated 95% confidence intervals (CI) from 1000 bootstrap samples of the data. Rate
CIs were estimated using similar methods. 6, 17 Count estimates and 95% CIs from age group-specific models were summed to calculate total numbers and rates of influenza excess P&I and R&C hospitalizations and deaths.
The summary measures of primary interest included total counts and rates of influenza excess P&I and R&C hospitalizations and deaths and median seasonal rate estimates of the same.
Medians were used rather than means because the data were positively skewed. Individual seasonal estimates were provided for context. We compared our estimates to the numbers of primary 
| RE SULTS
| Descriptive statistics for unmodelled hospitalizations, deaths, and virus surveillance
| Influenza excess P&I hospitalizations
| Influenza excess R&C hospitalizations
There were an estimated 30,811 (95%CI: 24 344, 37 176) excess R&C hospitalizations associated with influenza during the study period. 
| Influenza excess P&I deaths
There were an estimated 1064 (95%CI: 757, 1298) excess P&I deaths associated with influenza during the study period. The corresponding rate was 2.30 per 100 000 person-years (95%CI 1.64, 2.81). Influenza A(H1N1) and A(H3N2) were associated with the majority of excess P&I deaths with similar numbers by subtype ( 
| Influenza excess R&C deaths
There were an estimated 3828 (95%CI: 2060, 5433) excess R&C deaths associated with influenza during the study period. The cor- 
| Rate estimates for individual seasons
| Evolution of influenza A(H1N1) over time
The model coefficients for percentages of specimens testing positive influenza A(H1N1) from surveillance differed during pre-pandemic, pandemic, and post-pandemic time periods, indicating that the association between virus circulation and influenza excess hospitalizations and deaths differed during these periods (Table   S1 ). The greatest apparent differences occurred for excess P&I and R&C hospitalizations among persons 5-49 years and 50-64 years old. In these age groups, the coefficients were largest during the pandemic period, suggesting that pandemic influenza A(H1N1)
was associated with higher rates of excess hospitalization and death than pre-pandemic virus and that the rates of excess hospitalization and death associated with influenza A(H1N1) were lower in the post-pandemic period. A similar pattern was not apparent in the models for excess P&I and R&C hospitalizations among persons ≥65 years old or in the models for P&I and R&C excess deaths, where the age groups were not as finely stratified.
| Comparison to influenza-specific diagnoses and laboratory-confirmed influenza
Compared to hospitalizations and deaths with influenza recorded as the primary or underlying diagnosis, model estimates of total excess P&I hospitalizations, R&C hospitalizations, P&I deaths, and R&C deaths were 2.0, 3.4, 2.2, and 8.1 times higher, respectively (Table 4 ).
There were similar discrepancies for each season. virus. We, therefore, used local and regional hospital discharge, exposure to antigenically similar H1N1 viruses. 12, 15, 19, 23, 24 In our study, influenza A(H1N1) continued to be associated with relatively high rates of excess hospitalization and death among the younger age groups when circulating during seasons following the pandemic.
| D ISCUSS I ON
Time-varying coefficients for influenza A(H1N1) in models for influenza excess P&I and R&C hospitalizations among persons 5-49 years old and ≥65 years old increased in value during the pandemic period and decreased in value during the post-pandemic period, suggesting a transient increase in virulence in these age groups consistent with prior pandemics. 25 The above findings and our approach to estimating the statelevel burden of influenza apply to broader public health prevention and response efforts in several ways. First, we demonstrated that it is feasible to calculate state-level estimates of influenza burden using methods established for national public health purposes. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Second, the approach accounted for the known under-detection of influenza inherent to surveillance based on laboratory diagnosis or direct review of influenza diagnoses in administrative records. 4 Our total count estimates exceeded the number of hospitalizations and deaths documented in hospital discharge and death certificate data by a factor of 2-8, and the number of laboratory-confirmed influenza with prior findings that influenza A(H1N1) causes more severe disease in younger age groups compared to influenza A(H3N2), which tends to exact a greater toll on persons aged ≥65 years. 2, 3 Of note, the predominance of influenza A(H1N1) during the study period was reflected in higher estimates of influenza excess R&C hospitalization rates for A(H1N1) overall and by age group compared to national estimates from pre-pandemic years. 3 However, the comparability of our global state-level estimates to prior national estimates attests to the validity of our results.
The best application of the regression modeling approach may be to supply periodic state-level estimates of influenza burden in the form of total counts and median seasonal rates over several years.
This is because the models generally require at least 5 years of data to be accurate. 5 Furthermore, season-specific estimates may be less accurate than overall estimates based on the full dataset, because regression models may not fully capture seasonal fluctuations in influenza virulence. This was evident in our study, where seasonal estimates of influenza excess P&I hospitalizations were lower than the number of laboratory-confirmed influenza hospitalizations during the 2014-2015 and 2015-2016 seasons. Other investigators have addressed this issue by using separate model coefficients for influenza A for each season. 8, 11, 12 Our attempts to do so were limited by power and the occurrence of negative estimates. While negative estimates are a known limitation to this approach, they must be interpreted with caution. For example, confidence limits that cross zero should be interpreted as an indicator of lack of statistical significance, rather than as a possible protective effect. 24 To avoid misinterpretation, we allowed for the influenza A(H1N1) coefficient to change at biologically plausible time points coinciding with the emergence and evolution of the pandemic strain. Nevertheless, season-specific influenza burden may be better estimated using other methods. 22 It is also worthwhile noting that the interannual variability in influenza severity by season, type and subtype, and age will impact the overall summary measures.
A challenge to generating model estimates at the state-level is to obtain accurate virus surveillance data. We did not have complete influenza A subtyping data from local surveillance, so we assigned influenza A subtypes based on regional proportions of H1N1 to H3N2. Others have applied regional virus surveillance data to state-level outcomes. 13 We imputed influenza A(H1N1) surveillance findings during the first wave of the 2009 pandemic, because year-round surveillance data were not available. Other challenges may include lack of power to fit age-stratified models for less frequent outcomes.
There are a few potential limitations to our study. One was the inability to account for respiratory syncytial virus (or other pandemic, which may have affected our virus surveillance data. 12 Some authors have used additional indicators of influenza circulation, such as outpatient visits for influenza-like illness, which we did not evaluate. 16, 26 Finally, we did not compare our estimates to those extrapolated from surveillance for laboratory-confirmed influenza hospitalization. 22 Current United States methods of influenza disease burden estimation include surveillance for laboratory-confirmed influenza hospitalization captured by the US Influenza Hospitalization Surveillance Network (FluSurv-NET) and
adjustment for under-detection through the use of multipliers that account for testing practices and test characteristics. These methods were developed to create more timely national disease burden estimates that better capture season-to-season variation. 22, 27 A potential future study would be to develop these newer methods for state-level analyses and compare findings to state-level estimates using the "Serfling-type" models used in this study. 24 In summary, there were nearly 18 000 excess hospitalizations and 1000 excess deaths due to P&I causes, and 31 000 excess hospitalizations and 4000 excess deaths due to R&C causes associated with influenza in Colorado over nine influenza seasons. These local estimates and corresponding rates provide additional information to state public health officials for setting priorities and planning interventions to prevent and control influenza. The methods are feasible and could be used to produce periodic reports of state-level disease burden.
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